Kura Oncology Inc

Kura Oncology Inc

KURA · NASDAQ
KURA · NASDAQ
9.95
USD0.121.22%

Latest News

    @Investingcom
    Investingcom

    🇺🇸EARNINGS THIS WEEK: -CAL-MAINE FOODS -CONAGRA BRANDS -LAMB WESTON -DAVE & BUSTER’S -KURA SUSHI -PVH -LEVI STRAUSS -PAYCHEX -BLACKBERRY https://t.co/91wUWcdIbS 👈 $DIA $SPY $QQQ https://t.co/6vPszfnwti https://t.co/6yHbs5m3qF

    Analysts Recommendations

    Bullish

    Buy

    Strong Buy

    Buy

    Hold

    Sell

    Strong Sell

    Day Range

    9.77USD
    10.17USD

    52 Week Range

    7.36USD
    13.90USD

    Market Cap

    912.74MUSD

    lock-imagelock-image

    Get Full Access with Profit PRO

    See which Billionaires own this investment

    About

    General Information

    Type

    Common Stock

    Exchange

    NASDAQ

    Currency Code

    USD

    Currency Name

    US Dollar

    Country Name

    USA

    Country ISO

    US

    ISIN

    US50127T1097

    CUSIP

    50127T109

    Sector

    Healthcare

    Industry

    Biotechnology

    Fiscal Year End

    December

    IPO date

    -

    Updated At

    -

    Highlights

    PE Ratio

    -

    PEG Ratio

    -

    Book Value

    0.54

    Dividend Share

    -

    Dividend Yield

    -

    Earnings Share

    -3.37

    Wall Street Target Price

    31.85

    EPS Estimate Current Year

    -3.17

    EPS Estimate Next Year

    -2.34

    EPS Estimate Current Quarter

    -0.8756

    EPS Estimate Next Quarter

    -0.8922

    Most Recent Quarter

    -

    Profitability

    Revenue TTM

    77,225,000

    Gross Profit TTM

    -182,807,008

    EBITDA

    -316,799,008

    Profit Margin

    0.00%

    Return On Assets TTM

    -31.30%

    Return On Equity TTM

    -167.71%

    Revenue Per Share TTM

    0.875

    Qtly Revenue Growth YOY

    36.50%

    Diluted Eps TTM

    -3.37

    Qtly Earnings Growth YOY

    0.00%

    Valuation

    Trailing PE

    0.00

    Forward PE

    0

    Price Sales TTM

    11.8192

    Price Book MRQ

    18.8645

    Enterprise Value Revenue

    5

    Enterprise Value EBITDA

    -2

    Peers analysis

    • argenx NV ADR
      ARGXargenx NV ADR

      903.08

      3.20%
    • Moderna Inc
      MRNAModerna Inc

      227.40

      2.97%
    • Regeneron Pharmaceuticals Inc
      REGNRegeneron Pharmaceuticals Inc

      965.00

      0.55%
    • UCB SA
      UCBJFUCB SA

      314.92

      0.35%
    • argenx SE
      ARGNFargenx SE

      900.30

      0.00%
    • CSL Limited
      CMXHFCSL Limited

      139.16

      0.00%
    • Vertex Pharmaceuticals Inc
      VRTXVertex Pharmaceuticals Inc

      528.21

      -4.77%
    • Be
      ONCBeiGene, Ltd.

      355.10

      -2.26%
    • CSL Ltd
      CSLLYCSL Ltd

      34.64

      -2.01%
    • UCB SA ADR
      UCBJYUCB SA ADR

      153.70

      -1.47%

    FAQs

    What is Kura Oncology stock price today?

    What is Kura Oncology stock ticker?

    Is KURA stock price going up?

    What is the analyst recommendation for KURA?

    What is KURA market cap?

    Does KURA release financial reports?

    When is KURA next earnings date?

    What were KURA Earnings for the last quarter?

    What was KURA Revenue for the last quarter?

    What was KURA Net Income for the last quarter?

    Does KURA pay dividends?

    How many employees does KURA have?

    What is KURA EBITDA?

    How to buy KURA stocks?

    Should I invest in KURA stock?